Clinical factors and genetic variants associated with reverse seroconversion of hepatitis B virus surface antigen in patients with CD20 positive non-Hodgkin's lymphoma treated with rituximab
博士 === 國立陽明大學 === 臨床醫學研究所 === 104 === Rituximab can cause hepatitis B virus (HBV) reactivation in HBV surface antigen (HBsAg) seronegative patients with CD20 positive B-cell non-Hodgkin lymphoma (CD20+NHL), especially for those being seropositive to the antibody of core antigen (anti-HBc). Clinical...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2016
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/82492894764143782329 |